Tag: COVID-19 treatment

  • Bamlanivimab 700 Mg/20 Ml (35 Mg/Ml) Intravenous Solution (Eua) Antiviral Monoclonal Antibodies – Sars-Cov-2 Coronavirus

    Bamlanivimab 700 Mg/20 Ml (35 Mg/Ml) Intravenous Solution (Eua) Antiviral Monoclonal Antibodies – Sars-Cov-2 Coronavirus

    Discover the vital role of **Bamlanivimab 700 Mg/20 Ml (35 Mg/Ml)**, an Emergency Use Authorized monoclonal antibody treatment for COVID-19. This blog post examines its mechanism of action, ideal candidate profiles, and the importance of early intervention to mitigate severe symptoms. Learn how this therapeutic option is impacting high-risk patients amidst the ongoing pandemic.

  • Baricitinib Tablet

    Baricitinib Tablet

    Discover the transformative potential of Baricitinib, an oral Janus kinase inhibitor originally designed for rheumatoid arthritis, now making waves in the treatment of autoimmune conditions and COVID-19. This article delves into how Baricitinib works, its benefits, associated symptoms, and patient experiences, shedding light on its role in improving quality of life for those affected by…